Superoxide excess in hypertension and aging - A common cause of endothelial dysfunction

被引:363
作者
Hamilton, CA [1 ]
Brosnan, MJ [1 ]
McIntyre, M [1 ]
Graham, D [1 ]
Dominiczak, AF [1 ]
机构
[1] Univ Glasgow, Western Infirm, Gardiner Inst, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland
关键词
endothelium; nitric oxide; hypertension; experimental; aging;
D O I
10.1161/01.HYP.37.2.529
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
There is evidence in humans that hypertension and aging similarly impair endothelial function, although the mechanism remains unclear. Superoxide anion (O-2(-)) is a major determinant of nitric oxide (NO) bioavailability and thus endothelial function. We sought to determine the relationship between endothelial function, O-2(-), and age in normotensive Wistar-Kyoto (WKY) and stroke-prone spontaneously hypertensive rats (SHRSP). Aortic rings were removed from female WKY and SHRSP at 3 to 4 months (young) and 9 to 12 months (old). O-2(-) generation by aortic rings was measured before and after removal of the endothelium or incubation with N-G nitro-l-arginine methyl ester, diphenyleneiodonium, or apocynin, Levels of p22phox were studied with immunohistochemistry and used as a marker of NAD(P)H oxidase expression. NO bioavailability was significantly lower in old WKY compared with young WKY (P = 0.0009) and in old SHRSP compared with young SHRSP (P = 0.005). O-2(-) generation was significantly greater in old WKY compared with young WKY (P = 0.0001). Removal of the endothelium and N-G nitro-L-arginine methyl ester treatment resulted in a significant reduction in O-2(-) generation in old SHRSP (P = 0.009 and 0.001, respectively). Diphenyleneiodonium significantly reduced O-2(-) generation in 12-month WKY (P = 0.008) and 12-month SHRSP (P = 0.009). Apocynin attenuated O-2(-) generation by older WKY (P = 0.038) and SHRSP (P = 0.028), p22phox was increased in older animals compared with young. We conclude that NO bioavailability decreases with age in female WKY and SHRSP. O-2(-) generation increases with age in WKY and is higher in SHRSP and may contribute to the reduced NO by scavenging. NAD(P)H oxidase may contribute to the age-related increase in O-2(-).
引用
收藏
页码:529 / 534
页数:6
相关论文
共 32 条
  • [21] A central role for the endothelial NADPH oxidase in atherosclerosis
    Meyer, JW
    Schmitt, ME
    [J]. FEBS LETTERS, 2000, 472 (01): : 1 - 4
  • [22] HYPERCHOLESTEROLEMIA INCREASES ENDOTHELIAL SUPEROXIDE ANION PRODUCTION
    OHARA, Y
    PETERSON, TE
    HARRISON, DG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) : 2546 - 2551
  • [23] Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation - Contribution to alterations of vasomotor tone
    Rajagopalan, S
    Kurz, S
    Munzel, T
    Tarpey, M
    Freeman, BA
    Griendling, KK
    Harrison, DG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (08) : 1916 - 1923
  • [24] Nitric oxide and the regulation of blood pressure in the hypertension-prone and hypertension-resistant Sabra rat
    Rees, D
    BenIshay, D
    Moncada, S
    [J]. HYPERTENSION, 1996, 28 (03) : 367 - 371
  • [25] RUBANYI GM, 1986, AM J PHYSIOL, V250, P822
  • [26] Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production
    Skatchkov, MP
    Sperling, D
    Hink, U
    Mülsch, A
    Harrison, DG
    Sindermann, I
    Meinertz, T
    Münzel, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 254 (02) : 319 - 324
  • [27] Hypertension causes premature aging of endothelial function in humans
    Taddei, S
    Virdis, A
    Mattei, P
    Ghiadoni, L
    Fasolo, CB
    Sudano, I
    Salvetti, A
    [J]. HYPERTENSION, 1997, 29 (03) : 736 - 743
  • [28] VASODILATION TO ACETYLCHOLINE IN PRIMARY AND SECONDARY FORMS OF HUMAN HYPERTENSION
    TADDEI, S
    VIRDIS, A
    MATTEI, P
    SALVETTI, A
    [J]. HYPERTENSION, 1993, 21 (06) : 929 - 933
  • [29] TRAUB O, 1995, WESTERN J MED, V162, P439
  • [30] 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia
    Verhaar, MC
    Wever, RMF
    Kastelein, JJP
    van Dam, T
    Koomans, HA
    Rabelink, TJ
    [J]. CIRCULATION, 1998, 97 (03) : 237 - 241